In 2025, the US Surgeon General issued a pivotal advisory on alcohol and cancer risk, urging updated warning labels, patient…
Browsing: Colorectal Cancer
Digestive cancers therapeutics takes center stage as these cancers—esophageal, gastric, biliary, pancreatic, hepatocellular, and colorectal—account for 33-35% of global cancer…
Published: May 30, 2025 Pfizer shared results from the BRAFTOVI BREAKWATER trial at ASCO 2025. The trial tested BRAFTOVI® (encorafenib) with cetuximab…
Published: April 21, 2025 | OncologyTube.com A groundbreaking phase III study, published on April 11, 2025, in the Journal of…
Date: April 8, 2025 On April 8, 2025, the FDA granted regular approval to nivolumab (Opdivo) combined with ipilimumab (Yervoy)…
Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational…
The GALAXY Study has provided compelling data that highlights the predictive value of circulating tumor DNA (ctDNA) status in colorectal…
Dr. Suneel Kamath from the Cleveland Clinic – Young onset colorectal cancer (yoCRC) has been increasing over the past few…
Ethnic Minorities: Empowering to Increase Colorectal Cancer Screening Through Community Outreach Kimlin Ashing PhD By Kimlin Tam Ashing, PhDProfessor, Department…
SOX9: Can this protein enable a molecular reversal that could lead to colorectal cancer? Nilay Sethi MD By Nilay Sethi,…
Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase 3 Trial Dr. David…
iFrame is not supported! Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase…
Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase 3 Trial Dr. David…
iFrame is not supported! KRAS G12C Sotorasib: [2022] An Updated Overview in CRC Update On The CodeBreaK 100 Trial/KRAS…
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC Update On The CodeBreaK 100 Trial/KRAS G12C Sotorasib The CodeBreaK…
UCSF With FDA In Robotic Colorectal Surgery Trial: da Vinci SP [2022] Â The da Vinci SP Surgical Systems So…
We completed a geospatial epidemiological study, examining colorectal cancer mortality among those diagnosed before the age of 50. And this…
In this interview, I will present the results of a translational analysis of the Italian drug study. AtezoTRIBE is a…